Gastroenterology

The AJMC^® Gastroenterology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the stomach, digestive tract, colon, and more.

Latest News

January 24th 2025

FDA Approves Mirikizumab for Crohn Disease

By Skylar Jeremias

January 23rd 2025

Gene Variant, Season of Birth Identified as Celiac Disease Risk Factors

By Skylar Jeremias

January 14th 2025

Study Finds Link Between COVID-19 and Elevated Risk of GI Disorders

By Skylar Jeremias

January 14th 2025

Entering Peak Norovirus Season as Cases Rise Across the US

By Sophia Abene

January 13th 2025

What Adjunct Therapies Are Most Effective for IBS, IBD?

By Skylar Jeremias

Video Interviews

View All

January 12th 2025

Personalized Medicine in GI Cancer: Transforming Treatment With Technology, Lifestyle Insights

January 4th 2025

Empowering Patients With GI Cancer: Overcoming Immunotherapy Limitations

Continuing Medical Education

View All

January 26th 2025

Navigating Next-Generation Therapies for the Management of Acid-Related Disorders

1.5 Credits / Gastroenterology

January 26th 2025

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

More News

digestive trouble doll | Image credit: Alrandir - stock.adobe.com

January 9th 2025

Prucalopride Tablets for Chronic Idiopathic Constipation Launches, Approved for 180-Day CGT Designation

Gillian McGovern

The tablets are indicated for treatment of adults with chronic idiopathic constipation, with further research needed to assess efficacy and safety in children.

inflammatory bowel disease | Image credit: Aliaksandr Marko - stock.adobe.com

January 7th 2025

Stable Patient Satisfaction Found After Switching From Humira or Biosimilar Adalimumab to CT-P17

Deana Ferreri, PhD

A real-world study in France found patient satisfaction was stable after switching from either the reference product or a low-concentration adalimumab biosimilar to the adalimumab biosimilar CT-P17, a high-concentration, citrate-free formulation.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions